«Olfactory Mucosa

Below is an extended Olfactory Mucosa patents listing. Click here to return to the Olfactory Mucosa main in depth entry.

Patents :
US Patent No.	Title
5965552	Androstane steroids as neurochemical initators of change in human hypothalamic compositions and methods
6331534	Steroids as neurochemical stimulators of the VNO to alleviate pain
6344210	Composition for freshening nostrils and sinus cavities
6349719	Formulation and devices for monitoring the efficacy of the delivery of aerosols
6352980	Estrenes for inducting hypothalamic effects
6408250	Methods for characterizing, classifying, and identifying unknowns in samples
6410046	Administering pharmaceuticals to the mammalian central nervous system
6420337	Highly purified cytokine activating factor and methods of use
6451306	Methods for therapy of neurodegenerative disease of the brain
6506378	Vesicular monoamine transporter gene therapy in Parkinson's disease
6506801	Methods of treating anosmia and repopulating olfactory nerves with retinoids
6192882	Formulation and devices for monitoring the efficacy of the delivery of aerosols
6171575	Method of radioisotopic assessment of the integrity and function of the nose-brain barrier
6167888	Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal
5969168	Androstanes for inducing hypothalamic effects
5976893	Methods for identifying binding partners, agonists, and antagonist of a serine/threonine tyrosine kinase
5994568	Estrenes for inducing hypothalamic effects
6013766	Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
6042838	immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
6057439	Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
6066627	Steroids as neurochemical initiators of change in human blood levels of LH
6100046	Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit
6117860	Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
6140316	Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
6606567	Methods for characterizing, classifying, and identifying unknowns in samples
6646109	Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit
7087430	Human VNO cDNA libraries
7115258	Vesicular monoamine transporter gene therapy in parkinson's disease
7125995	Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
7138107	Inhibition of olfactory neurosensory function to treat eating disorders and obesity
7200432	Device for enhanced delivery of biologically active substances and compounds in an organism
7202035	Genetic markers for skatole metabolism
7319138	Human DRG11-Responsive Axonal Guidance and Outgrowth of Neurite (DRAGON) proteins and variants thereof
7329745	Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
7381800	Antibodies to HBIMF63 polypeptide
7400927	Method and system for psychological treatment by brain stimulation of the psychologically disordered object
7041292	Treating prostate cancer with anti-ErbB2 antibodies
7033598	Methods and apparatus for enhanced and controlled delivery of a biologically active agent into the central nervous system of a mammal
6994671	Apparatus and method for screening, olfactory mucosa stimulating compound found by the screening method, and therapeutic apparatus and electrode section for measurement
6647980	Method for administration of active substances to the olfactory region
6649618	Substituted amidoalkyl-uracils and their use
6663857	In vivo gene transfer using implanted retroviral producer cells
6663858	In Vivo gene transfer using implanted retroviral producer cells
6678553	Device for enhanced delivery of biologically active substances and compounds in an organism
6713293	Encapsulated cells containing an amplified expression vector as a drug delivery device
6741954	Selection method for odorants
6753323	Topical administration of amifostine and related compounds
6924357	Lipid binding protein 4
6949245	Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
7427417	Aromatherapy delivery system

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.